The study was small — just 48 adults — and lasted just over two months, so it’s not the final word. But the results add to evidence that GLP-1 drugs like Ozempic might help with cravings for things ...
The percentage of U.S. adults with obesity did not significantly rise from 2013 to 2023, though a small uptick in the rate of ...
Independence Blue Cross began limiting coverage of GLP-1 drugs on Jan. 1 to some medical conditions, but not obesity or weight loss.
Techno-Science on MSN2d
Social media and obesity: an avalanche of criticism 💬A team of researchers from UNIGE and HUG reveals that the majority of tweets published about obesity between 2019 and 2022 ...
The Trump administration has promised that addressing childhood obesity will be a key part of its “Make America Healthy Again ...
Although obese individuals are at greater risk of diabetes, high blood pressure or high cholesterol, not all obese people ...
That support doesn't go for teens. More U.S. adults believe it is a good thing than a bad thing for adults to use weight-loss ...
Obesity estimates for Aboriginal groups are based on single responses for Aboriginal identity. For the purposes of this report, the term "First Nations off-reserve " is used in lieu of "North American ...
Simply sign up to the Pharmaceuticals sector myFT Digest -- delivered directly to your inbox. In a few short years, excitement about groundbreaking anti-obesity drugs made Novo Nordisk Europe’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback